Lia DeGroot

While state Med­ic­aid pro­grams have in­creas­ing­ly loos­ened cov­er­age re­stric­tions on he­pati­tis C drugs in re­cent years, a team of re­searchers at Har­vard Uni­ver­si­ty re­cent­ly pub­lished

“If it’s Covid, Paxlovid.” That’s how Pfiz­er mar­kets its Covid-19 an­tivi­ral, even as the full re­sults of a study pub­lished in the New Eng­land Jour­nal

WuXi AppTec is en­list­ing more lob­by­ists to rep­re­sent its in­ter­ests be­fore Con­gress, where Chi­na hawks have pushed for lim­its on how the com­pa­ny works with

WASH­ING­TON — The US has some stock­piles of vac­cines for avian flu, FDA’s bi­o­log­ics head Pe­ter Marks said Mon­day as pub­lic health of­fi­cials raise the

Sen­ate HELP Com­mit­tee Chair Bernie Sanders (I-VT) is call­ing on No­vo Nordisk to dra­mat­i­cal­ly low­er the list prices of Ozem­pic and We­govy. It’s the lat­est

The FDA is strength­en­ing its fo­cus on us­ing math­e­mat­i­cal sim­u­la­tion and mod­el­ing to guide drug de­vel­op­ment with a new cen­ter of ex­cel­lence housed in the

WASH­ING­TON, DC – Supreme Court jus­tices ap­peared un­cer­tain on Tues­day that doc­tors and an­ti-abor­tion groups have stand­ing to chal­lenge the FDA’s cur­rent la­bel for the

The Biden ad­min­is­tra­tion is en­list­ing AI de­vel­op­ers to help dis­cov­er ways to tack­le cy­ber and ran­somware at­tacks against health­care sys­tems, which have been on the

Rep. Mike Gal­lagher (R-WI), the lead spon­sor of a close­ly watched bill that would pre­vent many US bio­phar­ma com­pa­nies from do­ing busi­ness with WuXi and

Law­mak­ers on the Sen­ate HELP com­mit­tee are putting pres­sure on HHS to amp up its re­sponse to the re­cent cy­ber­at­tack on Change Health­care, the fall­out